Evidence map›Paper›PMID 25087568›Full record

ArticleBiochemical pharmacology2014

Retinoic acid regulates cell cycle genes and accelerates normal mouse liver regeneration.

Hui-Xin Liu, Irene Ly, Ying Hu, Yu-Jui Yvonne Wan

Open access · greenAbstract read
In one paragraph

Article in Biochemical pharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Liver regeneration and ethanol detoxification: A new link in YAP regulation of ALDH1A1 during alcohol-related hepatocyte damage.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  10. Review
  11. Targeting fatty acid metabolism for fibrotic disorders.Archives of pharmacal research · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Retinoic acid and microRNA.Methods in enzymology · 2020
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Hui-Xin LiuDepartment of Medical Pathology and Laboratory Medicine, 4645 2nd Ave, Research Building III, University of California, Davis Health Systems, Sacramento, CA 95817,United States of America. Electronic address: huixinliu2012@gmail.com.
Irene LyDepartment of Medical Pathology and Laboratory Medicine, 4645 2nd Ave, Research Building III, University of California, Davis Health Systems, Sacramento, CA 95817,United States of America. Electronic address: Irene.ly@ucdmc.ucdavis.edu.
Ying HuDepartment of Medical Pathology and Laboratory Medicine, 4645 2nd Ave, Research Building III, University of California, Davis Health Systems, Sacramento, CA 95817,United States of America. Electronic address: yinghu0821@gmail.com.
Yu-Jui Yvonne WanDepartment of Medical Pathology and Laboratory Medicine, 4645 2nd Ave, Research Building III, University of California, Davis Health Systems, Sacramento, CA 95817,United States of America. Electronic address: yjywan@ucdavis.edu.
University of California, Davis · US

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Gina M Dayton · 2002 to 2026
$84.9M
Retinoids Xenobiotic Metabolism and Tumor PromotionR01CA053596 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI WAN, YU-JUI YVONNE · 1996 to 2014
$4.5M
Retinoic Acid, Its Receptors, and the LiverR01DK092100 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI WAN, YU-JUI YVONNE · 2011 to 2014
$1.4M
RETINOIC ACID RECEPTOR ALPHA-FETOPROTEIN AND HEPATOMAR29CA053596 · NCI · LA BIOMED RES INST/ HARBOR UCLA MED CTR · PI WAN, YU-JUI YVONNE · 1991 to 1995
–
NCI NIH HHS CA53596NCI NIH HHS P30 CA093373NCI NIH HHS R01 CA053596NIDDK NIH HHS DK092100NIDDK NIH HHS R01 DK092100
6 · The paper itself

Abstract

All-trans retinoic acid (RA) is a potent inducer of regeneration. Because the liver is the principal site for storage and bioactivation of vitamin A, the current study examines the effect of RA in mouse hepatocyte proliferation and liver regeneration. Mice that received a single dose of RA (25μg/g) by oral gavage developed hepatomegaly with increased number of Ki67-positive cells and induced expression of cell cycle genes in the liver. DNA binding data revealed that RA receptors retinoic acid receptor β (RARβ) and retinoid x receptor α (RXRα) bound to cell cycle genes Cdk1, Cdk2, Cyclin B, Cyclin E, and Cdc25a in mice with and without RA treatment. In addition, RA treatment induced novel binding of RARβ/RXRα to Cdk1, Cdk2, Cyclin D, and Cdk6 genes. All RARβ/RXRα binding sites contained AGGTCA-like motifs. RA treatment also promoted liver regeneration after partial hepatectomy (PH). RA signaling was implicated in normal liver regeneration as the mRNA levels of RARβ, Aldh1a2, Crabp1, and Crbp1 were all induced 1.5 days after PH during the active phase of hepatocyte proliferation. RA treatment prior to PH resulted in early up-regulation of RARβ, Aldh1a2, Crabp1, and Crbp1, which was accompanied by an early induction of cell cycle genes. Western blotting for RARβ, c-myc, Cyclin D, E, and A further supported the early induction of retinoid signal and cell proliferation by RA treatment. Taken together, our data suggest that RA may regulate cell cycle progression and accelerates liver regeneration. Such effect is associated with an early induction of RA signaling, which includes increased expression of the receptor, binding proteins, and processing enzyme for retinoids.

Indexed as

AnimalsCell CycleCell ProliferationGene Expression RegulationGenes, cdcLiver RegenerationMaleMiceProtein BindingRNA, MessengerTretinoinRNA, MessengerTretinoinHepatocyteNuclear receptorPartial hepatectomyProliferationPubchem CID: 444795Retinoic acid receptor

Identifiers

PMID25087568
PMCPMC4236911
OpenAlexW1979095013

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.